Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022

Studying the prevalence of SARS-CoV-2 specific antibodies (seroprevalence) allows for assessing the impact of epidemic containment measures and vaccinations and estimating the number of infections regardless of viral testing. We assessed antibody-mediated immunity to SARS-CoV-2 induced by infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Solastie, Anna, Nieminen, Tuomo, Ekström, Nina, Nohynek, Hanna, Lehtonen, Lasse, Palmu, Arto A., Melin, Merit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291939/
https://www.ncbi.nlm.nih.gov/pubmed/37289188
http://dx.doi.org/10.1080/22221751.2023.2222849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291939/
https://www.ncbi.nlm.nih.gov/pubmed/37289188
http://dx.doi.org/10.1080/22221751.2023.2222849

Ejemplares similares